Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Photocure ASA ( (PHCUF) ).
Photocure ASA has announced a share buyback program, intending to repurchase up to 200,000 shares for a maximum of NOK 20 million. The buyback aims to acquire shares at attractive prices to fulfill obligations under long-term incentive programs and potentially reduce outstanding shares. This move, managed by DNB Markets, reflects the company’s confidence in its current valuation and could impact its market positioning by optimizing capital structure.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in transformative solutions for bladder cancer patients. Their unique technology, which makes cancer cells glow bright pink, has improved health outcomes for patients globally. The company is headquartered in Oslo, Norway, and is listed on the Oslo Stock Exchange.
YTD Price Performance: -18.80%
Average Trading Volume: 388
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $139.3M
Learn more about PHCUF stock on TipRanks’ Stock Analysis page.